Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity (Q34052360)

30 July 2017

title

Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity (English)

1 reference

30 July 2017

1 reference

Michels JJ

1

1 reference

30 July 2017

Duigou F

series ordinal

2

1 reference

30 July 2017

Marnay J

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Breast Cancer Research and Treatment

30 July 2017

published in

1 reference

30 July 2017

volume

62

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

117-126

1 reference

Systemic adjuvant therapy for node-negative breast cancer: proven or premature?

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Significance of S-phase fraction and hormone receptor content in the management of young breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Grade and flow cytometric analysis of ploidy for infiltrating ductal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Cytometric DNA analysis and prognostic biomarkers in breast carcinoma. Expression of P53 product in the different ploidy classes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Proliferative activity of breast cancers increases in the course of genetic evolution as defined by cytogenetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

S-phase fraction and nuclear size in long term prognosis of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

S-phase fraction and breast cancer--a decade of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material. Correlations between flow cytometric, clinical, and pathologic variables. MMMCP Collaborative Group. Multicenter Morphometric Mammary Carcinoma Proj

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

The identification of informative parameters in the flow cytometric analysis of breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

DNA aneuploidy and cell proliferation in breast tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Ploidy Level of Human Breast Carcinoma Relation to Histopathologic Features and Hormone Receptor Content

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Flow cytometric DNA analysis as prognostic factor in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Prognostic significance of proliferative activity and ploidy in node-negative breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006451908322

7 January 2021

Identifiers

DOI

10.1023/A:1006451908322

1 reference

Dimensions Publication ID

30 July 2017

1031166126

0 references

1 reference